MannKind Corp (MNKD): Kapitalisasi marang pendapatan
MannKind Corporation (MNKD) maintains stable management as it develops its inhalation platform, a trend reflected in the upward volatility of the P/S ratio. Profit growth is driven by Tyvaso DPI royalties and a reduction in liabilities, while the value of 3.20 characterizes this level of market valuation. Financial stability is further bolstered by the implementation of ESG standards in production and the recycling of device components, optimizing the company's environmental footprint.
Rincian metrik lan analitis perusahaan Afrezza (MNKD)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas MannKind Corporation|MNKD - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal MannKind Corporation|MNKD - Gunggung utang perusahaan|Utang-utang marang aset resik MannKind|MNKD - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan MannKind|Rasio likuiditas darurat mannkindcorp.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
MNKD - Penghasilan resik|Penghasilan resik sing dikarepake MannKind Corporation|MNKD - Pangali P/E|Prakiraan rega marang bathi Afrezza|MNKD - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MannKind|MNKD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku MannKind|MNKD - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan mannkindcorp.com|MNKD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep MannKind Corporation
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:MNKD, MannKind Corp
Stable pharmaceutical capacity utilization and the automation of packaging lines at MannKind Corporation (MNKD) create a reliable foundation for revenue scaling. By analyzing the P/S ratio chronology, an investor determines the market value of a single dollar of sales, which allows for an assessment of the expectations priced in and an understanding of how resilient current quotes are to potential fluctuations in business growth rates.
Pesaing MannKind Corporation
HLN (Haleon) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue Inc KVUE|Verona Pharma Corp - Rasio rega marang pendapatan|MENS: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Rasio rega marang pendapatan|Perrigo Company PLC - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan alvotech.com|Multiplikator P/S Liquidia Technologies|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|ANIP: Rasio rega marang dodolan|Rasio rega marang pendapatan Amphastar Pharmaceuticals Inc AMPH|Multiplikator P/S Pacira PCRX|ARS Pharmaceuticals Inc - Multiplikator P/S|TBPH - Multiplikator P/S|AQST (Aquestive Therapeutics) - Kapitalisasi marang pendapatan|scPharmaceuticals, Inc. (SCPH) - Multiplikator P/S|Kapitalisasi marang pendapatan TECX|Multiplikator P/S Tonix Pharma|Kapitalisasi marang pendapatan SXTC (SXT Pharmaceuticals)|EPRX: Rasio rega marang dodolan|BioHarvest Sciences - Kapitalisasi marang pendapatan|EXOZ: Rasio kapitalisasi marang pendapatan|ORMP - Rasio rega marang pendapatan|ENTX: Rasio rega marang pendapatan|HYFT: Multiplikator P/S|Kapitalisasi marang pendapatan ABVC BioPharma Inc|CPIX (Cumberland Corp) - Multiplikator P/S|Multiplikator P/S quantumbiopharma.com|Multiplikator P/S FGEN|Kapitalisasi marang pendapatan Telomir Pharmaceuticals, Inc. TELO|Multiplikator P/S RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Rasio rega marang dodolan|RLYB: Kapitalisasi marang pendapatan|lexariabioscience.com (LEXX) - Kapitalisasi marang pendapatan|Pulmatrix Inc (PULM) - Rasio rega marang pendapatan|PTHL: Kapitalisasi marang volume dodolan|APM (Aptorum Group Ltd) - Multiplikator P/S|Lyra Therapeutics Inc (LYRA) - Koefisien rega marang pendapatan|Multiplikator P/S IBO|Kapitalisasi marang volume dodolan TNFA|cbdMD, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PRFX|Altamira Therapeutics Ltd. - Multiplikator P/S|LIPO: Rasio rega marang pendapatan|OPTN: Multiplikator P/S|Rasio rega marang dodolan PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - Multiplikator P/S|PTPI (Petros Pharmaceuticals Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S QLI|SLRN - Rega marang dodolan|Multiplikator P/S TFFP (TFF Pharmaceuticals, Inc)
